Antihuman MPO FITC Cat No 340580,DAPI BV421 Cat No 564907,Antihuman Elastase PE Cat No 568908,Antih
Indian Council Of Medical Research (icmr)
CHENNAI, TAMIL NADU
Bid Publish Date
17-Jun-2026, 4:11 pm
Bid End Date
18-Jul-2026, 5:00 pm
Value
₹2,80,000
Location
Progress
Quantity
21
Category
Antihuman CD3 APC H7
Bid Type
Two Packet Bid
Indian Council Of Medical Research (icmr) has released a public tender for Antihuman CD3 APC H7, Antihuman CD4 PE, Antihuman CD8 FITC, Antihuman IL2 BV421, Antihuman TNFa APC, Antihuman IFN g PE Cy7, Antihuman CD45 BV711 in CHENNAI, TAMIL NADU. Quantity: 21. Submission Deadline: 18-07-2026 17: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Antihuman CD3 APC H7 , Antihuman CD4 PE , Antihuman CD8 FITC , Antihuman IL2 BV421 , Antihuman TNFa APC , Antihuman IFN g PE Cy7 , Antihuman CD45 BV711
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Council Of Medical Research (icmr)
CHENNAI, TAMIL NADU
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Indian Council Of Medical Research (icmr)
MUMBAI, MAHARASHTRA
Institute Of Liver And Biliary Sciences
SOUTH DELHI, DELHI
Tender Results
Loading results...
Antihuman CD3 APC H7
Please see specification document
Antihuman CD4 PE
Please see specification document
Antihuman CD8 FITC
Please see specification document
Antihuman IL2 BV421
Please see specification document
Antihuman TNFa APC
Please see specification document
Antihuman IFN g PE Cy7
Please see specification document
Antihuman CD45 BV711
Please see specification document
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Antihuman CD3 APC H7 | Please see specification document | 3 | nos | [email protected] | 15 | |
| 2 | Antihuman CD4 PE | Please see specification document | 3 | box | [email protected] | 15 | |
| 3 | Antihuman CD8 FITC | Please see specification document | 3 | box | [email protected] | 15 | |
| 4 | Antihuman IL2 BV421 | Please see specification document | 3 | nos | [email protected] | 15 | |
| 5 | Antihuman TNFa APC | Please see specification document | 3 | box | [email protected] | 15 | |
| 6 | Antihuman IFN g PE Cy7 | Please see specification document | 3 | box | [email protected] | 15 | |
| 7 | Antihuman CD45 BV711 | Please see specification document | 3 | box | [email protected] | 15 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
18-Jul-2026, 5:00 pm
Opening Date
18-Jul-2026, 5:30 pm
N/a
📍 GAUTAM BUDDHA NAGAR, UTTAR PRADESH
All India Institute Of Medical Sciences (aiims)
📍 SOUTH DELHI, DELHI
Indian Army
📍 ANANTHNAG, JAMMU & KASHMIR
Indian Council Of Medical Research (icmr)
📍 BHOPAL, MADHYA PRADESH
All India Institute Of Medical Sciences (aiims)
📍 SOUTH DELHI, DELHI
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS